PCM
AGN

Polaris Capital Management’s Allergan plc AGN Stock Holding History

Polaris Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-103,066
Closed -$18.3M – 106
2020
Q1 		$18.3M Sell
103,066
-182,900
-64% -$34.4M 1.1% 33
2019
Q4 		$54.7M Buy
285,966
+4,813
+2% +$868K 2.25% 13
2019
Q3 		$47.3M Buy
281,153
+5,500
+2% +$896K 2.13% 17
2019
Q2 		$46.2M Buy
275,653
+1,700
+0.6% +$235K 1.95% 15
2019
Q1 		$40.1M Buy
273,953
+5,600
+2% +$812K 1.67% 25
2018
Q4 		$35.9M Buy
268,353
+18,500
+7% +$3.03M 1.64% 22
2018
Q3 		$47.6M Sell
249,853
-5,366
-2% -$986K 2.07% 13
2018
Q2 		$42.5M Sell
255,219
-122,065
-32% -$19.6M 1.97% 17
2018
Q1 		$63.5M Buy
377,284
+240,065
+175% +$40.3M 2.34% 11
2017
Q4 		$22.4M Buy
137,219
+16,800
+14% +$3.01M 1.05% 34
2017
Q3 		$24.7M Buy
120,419
+19,900
+20% +$4.63M 1.38% 33
2017
Q2 		$24.4M Buy
100,519
+16,775
+20% +$3.94M 1.44% 31
2017
Q1 		$20M Buy
83,744
+125
+0.1% +$29.1K 1.42% 30
2016
Q4 		$17.6M Buy
83,619
+30,300
+57% +$6.28M 1.14% 36
2016
Q3 		$12.3M Buy
53,319
+900
+2% +$220K 0.96% 37
2016
Q2 		$12.1M Buy
52,419
+300
+0.6% +$69.2K 1.05% 36
2016
Q1 		$11.3M Buy
52,119
+6,994
+15% +$2M 0.97% 37
2015
Q4 		$14.1M Buy
45,125
+11,000
+32% +$3.27M 1.43% 25
2015
Q3 		$9.28M Buy
34,125
+3,500
+11% +$1.08M 1.12% 30
2015
Q2 		$9.29M Hold
30,625
– – 1.14% 27
2015
Q1 		$9.11M Sell
30,625
-4,500
-13% -$1.28M 1.27% 25
2014
Q4 		$9.04M Buy
+35,125
New +$8.78M 1.52% 25

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Polaris Capital Management's AGN Position: Q2 2020 in Review

Polaris Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 103,066 shares — an estimated $18.3M sold.

Polaris Capital Management first reported a position in AGN in Q4 2014 and held it in 22 quarters. The position peaked at $63.5M in Q1 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Polaris Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Polaris Capital Management sold 103,066 Allergan plc shares in Q2 2020, an estimated $18.3M.
  • Polaris Capital Management first reported a position in Allergan plc in Q4 2014 and held it in 22 quarters.
  • Polaris Capital Management's Allergan plc position peaked at $63.5M in Q1 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Polaris Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.